EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/08/2026
Back to search
Official data from USPTO
ALDEYRA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALDEYRA THERAPEUTICS
ST13
US500000086223081Class
5
Filing
86223081
Registration
4818830
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
07/09/2026
Trademark type
Word
Nice classes
5
Filing date
03/17/2014
Registration date
09/22/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/04/2022
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/17/2015
First use in commerce
03/17/2015
Drawing code
4
Owner type
03
Owner location
Lexington, MA, US
Examiner
SHANOSKI, JOANNA MARIE
Current location
Historical data usage
Holders and representatives
Holders
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc.
Representatives
Nathan T. Harris LANDO & ANASTASI, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents for lowering aldehyde levels by trapping aldehydes
Publications
History of USPTO decisions and trademark events.
39 publications found
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
01/10/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
09/22/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/22/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/04/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/04/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/04/2022
E815
TEAS SECTION 8 & 15 RECEIVED
09/29/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/26/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/26/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/26/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
08/21/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/20/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
08/20/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/19/2015
EX1G
SOU EXTENSION 1 GRANTED
08/19/2015
EXT1
SOU EXTENSION 1 FILED
08/05/2015
EEXT
SOU TEAS EXTENSION RECEIVED
08/05/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/04/2015
IUAF
USE AMENDMENT FILED
07/09/2015
EISU
TEAS STATEMENT OF USE RECEIVED
07/09/2015
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
02/10/2015
PUBO
PUBLISHED FOR OPPOSITION
12/16/2014
NPUB
NOTICE OF PUBLICATION
11/26/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/13/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/07/2014
ACEC
AMENDMENT FROM APPLICANT ENTERED
11/06/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2014
ALIE
ASSIGNED TO LIE
10/31/2014
PAPER RECEIVED
10/31/2014
CNRT
NON-FINAL ACTION MAILED
06/24/2014
CNRT
NON-FINAL ACTION WRITTEN
06/23/2014
DOCK
ASSIGNED TO EXAMINER
06/19/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2014
NWAP
NEW APPLICATION ENTERED
03/20/2014
Continuous trademark protection
Get notified about every new filing that threatens ALDEYRA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.